Exploring red blood cells as a novel tolerogenic approach for Factor VIII inhibitors employing immuno-dominant FVIII derived peptides presented on MHC class II - Miranda, M; Brandsma, E; Kaijen, P; Van Alphen, F; Van Bruggen, R; Fijnvandraat, K; Lacroix-Desmazes, S; Voorberg, J (Hämostaseologie, 2023)